In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...
I was 26 when I reached 267 pounds. At that weight I was constantly dealing with lower back pain and high blood pressure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback